Decay-accelerating factor in the cardiomyocytes of normal individuals and patients with myocardial infarction
- PMID: 1700536
- DOI: 10.1007/BF01605780
Decay-accelerating factor in the cardiomyocytes of normal individuals and patients with myocardial infarction
Abstract
The presence of decay-accelerating factor (DAF) was clearly demonstrated on the surface of normal cardiomyocytes. In patients who had died of myocardial infarction (MI) cardiomyocytes displayed different appearances: outside the ischaemically damaged region the myocytes showed no significant variations in DAF expression when compared with controls without MI. Within myocardial zones damaged by ischaemia, however, apparently normal myocytes showed large gaps in surface staining of DAF or formed clusters which were entirely devoid of reactivity with anti-DAF antibodies. The number of DAF-deficient myocytes increased with the extent of necrosis and also with the number of days between onset of MI and death. Even though injury to myocytes is to a large extent related to anoxia and to the presence of free oxygen radicals, the complement system also appears to be involved; DAF may have protective functions against complement-mediated injury. We speculate that phospholipase may be involved in the removal of DAF from the cardiomyocyte surface.
Similar articles
-
Localization of decay accelerating factor in normal and diseased kidneys.Kidney Int. 1989 Jul;36(1):100-7. doi: 10.1038/ki.1989.167. Kidney Int. 1989. PMID: 2478749
-
Heterogenous expression of decay accelerating factor and CD59/membrane attack complex inhibition factor on paroxysmal nocturnal haemoglobinuria (PNH) erythrocytes.Br J Haematol. 1991 Aug;78(4):545-50. doi: 10.1111/j.1365-2141.1991.tb04486.x. Br J Haematol. 1991. PMID: 1716957
-
Heightened complement sensitivity of acquired immunodeficiency syndrome lymphocytes related to diminished expression of decay-accelerating factor.Proc Natl Acad Sci U S A. 1989 Jun;86(11):4205-9. doi: 10.1073/pnas.86.11.4205. Proc Natl Acad Sci U S A. 1989. PMID: 2471198 Free PMC article.
-
Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.J Exp Med. 1985 Jul 1;162(1):75-92. doi: 10.1084/jem.162.1.75. J Exp Med. 1985. PMID: 2409211 Free PMC article. Review.
-
Decay-accelerating factor (DAF): a review of its function and structure.Acta Med Scand Suppl. 1987;715:111-21. doi: 10.1111/j.0954-6820.1987.tb09911.x. Acta Med Scand Suppl. 1987. PMID: 2438906 Review. No abstract available.
Cited by
-
Regulation of complement membrane attack complex formation in myocardial infarction.Am J Pathol. 1993 Jul;143(1):65-75. Am J Pathol. 1993. PMID: 7686345 Free PMC article.
-
Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas.Br J Cancer. 1992 Nov;66(5):810-4. doi: 10.1038/bjc.1992.365. Br J Cancer. 1992. PMID: 1384641 Free PMC article.
-
The alternative complement pathway regulates pathological angiogenesis in the retina.FASEB J. 2014 Jul;28(7):3171-82. doi: 10.1096/fj.14-251041. Epub 2014 Mar 25. FASEB J. 2014. PMID: 24668752 Free PMC article.
-
Membrane attack complex of complement and 20 kDa homologous restriction factor (CD59) in myocardial infarction.Virchows Arch. 1997 Apr;430(4):327-32. doi: 10.1007/BF01092756. Virchows Arch. 1997. PMID: 9134044
-
Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment.J Virol. 1995 Jun;69(6):3873-7. doi: 10.1128/JVI.69.6.3873-3877.1995. J Virol. 1995. PMID: 7538177 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous